• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Obstetrics

Immediate postpartum intrauterine device insertion associated with increased risk of device expulsion: the APEX-IUD study

byYuchen DaiandMichael Pratte
February 28, 2022
in Obstetrics, Public Health
Reading Time: 2 mins read
Family planning providers use long acting contraception more than general population
Share on FacebookShare on TwitterShare on LinkedIn

1. Among postpartum breastfeeding women with known intrauterine device insertion, 5-year cumulative incidence of device expulsion was highest for insertions at 0-3 days and lowest for >6 to 14 weeks postpartum.

2. Compared to postpartum non-breastfeeding women, breastfeeding at the time of intrauterine device insertion was associated with an approximately 30% lower risk of device expulsion.

Evidence Rating Level: 2 (Good)

Study Rundown: Intrauterine devices (IUDs) are a highly effective form of contraception that are commonly inserted in the postpartum period, most often at 4-6 weeks after delivery. However, they are increasingly being inserted earlier in the immediate postpartum period and it is unclear how this difference in timing of device insertion is associated with maternal breastfeeding and risk of expulsion and unintended pregnancy. This cohort study assessed the association of postpartum timing of IUD insertion in conjunction to breastfeeding status with incidence and risk of IUD expulsion. The main outcomes were incidence rates and adjusted hazard ratios (aHRs), estimated via propensity scores to adjust for confounding. Among 326 658 women who were ≤52 weeks postpartum with known breastfeeding status at the time of IUD insertion, 5-year cumulative incidence of IUD expulsion was highest for insertions at 0-3 days and lowest for >6 to 14 weeks. Overall, the risk of IUD expulsion was low, higher in non-breastfeeding women, but highest in those with insertions at 0-3 days postpartum. Most expulsions were recognized within 12 weeks after insertion. A limitation of this study was the lack of information on lactational amenorrhea which may be associated with risk of expulsion and thus, a confounding factor.

Click to read the study in JAMA Network Open

Relevant Reading: The safety of intrauterine devices in breastfeeding women: a systematic review

RELATED REPORTS

The Scan by 2 Minute Medicine®: Keeping up with Keto, Feeding with HIV, Lung Cancer Overhaul and Catastrophic Chip Challenge

Breastfeeding may have a limited protective effect on some mental health disorders in children later in life

In-Depth [retrospective cohort]: This cohort study (APEX-IUD) included 326 658 women (mean [SD] age, 32.0 [8.3] years; 137 102 [42.0%] non-Hispanic White, 38 911 [11.9%] Asian or Pacific Islander; 56 180 [17.2%] Hispanic other) aged ≤50 years with an IUD insertion between 2001 and 2018. Analysis on a subcohort of breastfeeding women at ≤52 weeks postpartum (N = 94 817) was categorized by timing of IUD insertion postpartum: 0-3 days, 4 days to 6 weeks, >6 to 14 weeks, >14 to 52 weeks, and non-postpartum (>52 weeks or no evidence of delivery). Overall, the most common IUDs were levonorgestrel-releasing (259 234 [79.4%]). There were 8943 IUD expulsions, where the 5-year cumulative incidence was highest for insertions 0-3 days postpartum (10.73%; 95%CI, 9.12%-12.61%) and lowest for insertions >6 to 14 weeks postpartum (3.18%; 95%CI, 2.95%-3.42%). Using the non-postpartum IUD insertion cohort as the reference, aHRs were 5.34 (95%CI, 4.47-6.39) for 0-3 days postpartum; 1.22 (95%CI, 1.05-1.41) for 4 days to 6 weeks; 1.06 (95%CI, 0.95-1.18) for >6 to 14 weeks; and 1.43 (95%CI, 1.29-1.60) for those >14 to 52 weeks. Within the subcohort analysis, 5-year cumulative incidence was 3.49% (95%CI, 3.25%-3.73%) for breastfeeding women and 4.57% (95%CI, 4.22%-4.95%) for non-breastfeeding women, where the adjusted HR for breastfeeding vs non-breastfeeding was 0.71 (95%CI, 0.64-0.78).

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: breastfeedingintrauterine device (IUD)IUD
Previous Post

Axicabtagene ciloleucel improves event-free survival in relapsed or refractory large B-cell lymphoma

Next Post

Patients discharged from inpatient psychiatric care may benefit from a text support program

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Keeping up with Keto, Feeding with HIV, Lung Cancer Overhaul and Catastrophic Chip Challenge

May 28, 2024
Obstetrics

Breastfeeding may have a limited protective effect on some mental health disorders in children later in life

October 20, 2023
Wellness

Wellness Check: Mental Health

October 19, 2023
Obstetrics

Religious affiliation may influence the type of contraception used by women in the postpartum period

April 24, 2023
Next Post
Health text messaging collage: a smartphone with a blank screen, paper speech bubbles and a folded envelope

Patients discharged from inpatient psychiatric care may benefit from a text support program

Second-line tisagenlecleucel does not improve outcomes in B-cell lymphoma

Congenital Zika syndrome is associated with higher risk of death

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • In online experiment, AI disagreement increased perceived laziness and uncertainty toward an LLM-simulated doctor
  • Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity
  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.